Board Certified in 2006
Board Certified in 2006
Bryn Mawr Medical Arts Pavilion
825 Old Lancaster Road
Bryn Mawr, PA 19010
6 Lancaster Ave.
Wynnewood, PA 19096
Jefferson Medical College
Hospital of the University of Pennsylvania
Yale-New Haven Hospital
2004-2006 3M Pharmaceuticals. 1494-IMIQ MC, Yale HIC #26504. Phase III Vehicle-controlled, Double-blind Study to Assess the Safety and Efficacy of Imiquimod Cream, 5% for the Treatment of Molluscum Contagiosum in Pediatric Subjects. Yale Children’s Clinical Research Center. Richard Antaya, MD, Principal Investigator, Danielle M. DeHoratius, MD, Co-Investigator, Suguru Imaeda, MD, Co-Investigator
1999, 2001, 2003: United States Medical Licensing Exam, Steps 1, 2, & 3
9/2005 – present: Commonwealth of Pennsylvania Medical License
8/2006: American Board of Dermatology
3/2006: DEA License Obtained
2003 – present: American Academy of Dermatology, Fellow
2005 – present: Women’s Dermatologic Society
2004 – 2008: The American Society of Dermatologic Surgery
2003 – 2008: Dermatology Foundation
2005 – 2008: The Skin Cancer Foundation
2004 – present: Lafayette College Alumni Admission Representative
2004 – 2006: Graduate Member Education Committee, Yale-New Haven Hospital, Resident Representative
2005 – 2006: Friends of Lafayette Field Hockey Committee
1995 – 1996: Professor Search Committee, Psychology Dept., Lafayette College
10/2005 DeHoratius D, Glusac E, Girardi M. A 34 year-old woman with vascular lesions and schwannomas presented at the New England Dermatologic Society Meeting, Oct. 1, 2005 at Yale-New Haven Hospital.
10/2005 DeHoratius D, Kucher C, Watsky K. A 63 year-old woman with skin colored facial papules presented at the New England Dermatologic Society Meeting, Oct. 1, 2005 at Yale-New Haven Hospital.
10/2003 & 4/2004
DeHoratius D, Lazar A, Subtil A, Braverman I, Antaya, R. Widespread Acanthosis Nigricans presented at the New England Dermatologic Society Meeting, Oct. 25, 2003 at Yale-New Haven Hospital. Also presented as Case 43 at the Atlantic Dermatologic Society Meeting, Apr. 17, 2004 at Massachusetts General Hospital.
10/2003 DeHoratius D, Mariwalla K, Glusac E, Edelson R. A 41 year-old woman with rippled hyperpigmentation on the upper back and a history of medullary thyroid carcinoma presented at the New England Dermatologic Society Meeting, Oct. 25, 2003 at Yale-New Haven Hospital.
2005 Barry CI, Rashidi H, DeHoratius DM, Heald P, Bifulco C, Cowper S. Cutaneous T-cell Lymphoma Associated with Juvenile Rheumatoid Arthritis and Methotrexate Therapy. Accepted for Duel in Dermatopathology for the 42nd Annual Meeting of the American Society for Dermatopathology.
2001 – 2002 Cell Cycle Progression of Normal and Malignant Keratinocytes in the Anchorage Independent State as Determined by BrDU Incorporation, Ulrich Rodeck MD, Associate Professor, Department of Dermatology and Cutaneous Biology, Jefferson Medical College.
2001 – 2002 Effects of Ultraviolet B Radiation on Expression of the Metastasis-Associated Protein (MTA)1 in Immortalized Keratinocytes, Ulrich Rodeck MD, Associate Professor, Department of Dermatology and Cutaneous Biology, Jefferson Medical College.
2001 – 2002 Flow Cytometric Determination of Death Receptor Expression in Normal Keratinocytes, Ulrich Rodeck MD, Associate Professor, Department of Dermatology and Cutaneous Biology, Jefferson Medical College.
1997 – 1998 Lymphocyte Profiles in Patients Receiving Adoptive Immunotherapy for Non-Hodgkins Lymphoma, David Porter MD, Director, Allogeneic Bone Marrow Transplant Unit, University of Pennsylvania, Cancer Center.
1997 – 1998 Identification and Quantitation of Fetal Nucleated Erythrocytes in Cord Blood as a Monitor of Fetal Distress, Peter Argenta MD, Resident, Dept. of Ob/Gyn, University of Pennsylvania, School of Medicine.
1997 – 1998 Effect of Platelet Receptor Occupancy and Inhibition of Aggregation by GPIIb/IIIa Antagonists, Shiv Kapoor PhD, University of Pennsylvania.
Let’s get started! Answer a few basic questions to see if Jumpstart© with OPTIFAST® Program is right for you.